Specifically, no significant alterations were observed in MasR-AA levels in post-COVID patients relative to other groups, and levels of AT2-AA were significantly higher in post-COVID patients than in the after-COVID control group, although this increase did not reach statistical significance when compared with uninfected patients.
← all excerpts
Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients.
1
—
—